Home
About Us
Issues
Authors
Reviewers
Users
Subscription
Our Other Journals
Site map
Aims and Scope
Salient Features
Editorial Board
Editorial Statements
Editorial-PeerReview Process
Publication Ethics & Malpractice
Ijars Performance
Journal Policy
Contact Us
Current Issue
Forthcoming
Article Archive
Access Statistics
Simple Search
Advanced Search
Submit an Article
Instructions
Assistance
Publication Fee
Paid Services
Apply As Reviewer
Acknowledgment
Register Here Edit Register
Register For Article Submission
Login Here Logout
Login For Article Submission
Annual
Buy One Issue
Payment Options
How to Order
JCDR
IJNMR
NJLM

 

Welcome : Guest

Users Online :

 

 

 

 

 

 

 

 

Case Series

Year :2025 Month : March-April Volume : 14 Issue : 2 Page : SS01 - SS03 Full Version

Surgical Excision and Postoperative Radiotherapy for Chest Keloids: A Case Series


Komala Abhishek Reddy, Ashish Kumar Gupta, Shashank Lamba
1. Assistant Professor, Department of Plastic Surgery, Christian Medical College, Vellore, Tamil Nadu, India. 2. Professor, Department of Plastic Surgery, Christian Medical College, Vellore, Tamil Nadu, India. 3. Professor, Department of Plastic Surgery, Christian Medical College, Vellore, Tamil Nadu, India.
 
Correspondence Address :
Dr. Komala Abhishek Reddy,
Assistant Professor, Department of Plastic Surgery, Christian Medical College, Vellore-632002, Tamil Nadu, India.
E-mail: karonline@gmail.com
 
ABSTRACT

: Keloids are a common fibroproliferative disorder and various medical and surgical treatment options are available for managing them. However, some keloids can be resistant to these treatments. In such cases, the current recommendation is to perform surgical excision followed by early radiotherapy to reduce the risk of recurrence. A retrospective analysis was conducted on patients who underwent keloid excision at a tertiary care centre between January 2011 and December 2020. The study included 10 patients (2 females, 8 males) with a mean follow-up period of five years. Unfortunately, all keloids recurred, with the average time to recurrence being approximately two years postsurgery. After a recurrence, all patients received conservative management. It is suggested that ethnicity may contribute to the high recurrence rate observed. Further studies, including randomised controlled trials from the Indian subcontinent, are needed to determine the most effective treatment options for keloids.
Keywords : Fibroblasts, Radiation, Scars, Skin graft, Surgery
DOI and Others : DOI: 10.7860/IJARS/2025/75009.3041

Date of Submission: Sep 07, 2024
Date of Peer Review: Nov 06, 2024
Date of Acceptance: Jan 01, 2025
Date of Publishing: Mar 01, 2025

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Sep 11, 2024
• Manual Googling: Dec 24, 2024
• iThenticate Software: Dec 30, 2024 (4%)

ETYMOLOGY: Author Origin

EMENDATIONS: 6
 
INTRODUCTION

Keloids are fibroproliferative disorders in the reticular dermis that result from prolonged inflammation after trauma. Very few studies are available on the incidence of keloids. The incidence of keloids is 5% in Africans, 0.1-1% in Asians and less than 1% in Europeans and North Americans (1). This difference in the prevalence of the disease may be due to genetic and ethnic factors (2).

None of the surgical or medical treatments can permanently remove keloids while restoring the aesthetic appearance of the affected skin. Despite extensive research, keloids remain refractory lesions. Therefore, multiple single or combined modality treatment options are available, which include intralesional corticosteroid injections, 5-fluorouracil (5-FU), silicone gel sheets, compression therapy, cryotherapy, surgery and radiation. Surgical intervention is performed after the failure of medical management (3). Surgical intervention alone has a recurrence rate of 45-100% (4). The recurrence rate decreases when combined with postoperative radiotherapy (1).

Postoperative (adjuvant) radiotherapy significantly reduces the recurrence rate with a low risk of carcinogenicity. Electron beam radiotherapy, brachytherapy and photon beam therapy are the standard radiation delivery techniques. The efficacy of these radiation modalities is comparable for keloids and each modality has its advantages and disadvantages (5).
 
 
Case Report

Keloids were primarily managed conservatively through intralesional therapies. The earlobe was the most common site, showing a good response to these conservative treatments. A total of 36 patients had presternal keloids; however, these did not respond to conservative management. Among these, 25 patients refused consent for radiation exposure. A total of 11 patients underwent excision followed by adjuvant radiotherapy, but two of them did not attend follow-up appointments regularly. As a result, only nine cases of presternal keloids were included in the present study, along with one refractory thigh keloid, which featured a long follow-up period (Table/Fig 1). Following the excision of the keloid, either primary closure was performed or a skin graft was applied. Patients were started on 16-24 Gy of external beam radiotherapy within 24 hours of excision, administered in divided doses over 4 to 5 days. The Biologically Effective Dose (BED) was more than 30 Gy for all patients, as recommended in the literature (6). Follow-ups were conducted with patients to monitor for recurrence of symptoms. A few representative cases have been presented in (Table/Fig 2),(Table/Fig 3),(Table/Fig 4).

The following are examples of a few other cases that had symptomatic improvement followed by a recurrence of symptoms (Table/Fig 5).

Donor site morbidity: A few patients were found to have keloid formation at the donor site (Table/Fig 6). Since this finding was not present uniformly in all patients, it may be due to probable deeper dermal involvement at the sites.

Radiotherapy-related side-effects: Three patients experienced temporary pigmentation. No other obvious radiation-related adverse effects were noted. A negligible risk of carcinogenicity has been reported in the literature.
 
 
Discussion

Surgical intervention is considered when initial treatment options prove ineffective. Surgical intervention without adjuvant treatment has a recurrence rate of 45-100% (4). Common surgical procedures include the double-layer intradermal continuous suture technique, local flaps and skin grafts. Adjuvant radiotherapy is commonly administered, as meta-analysis show that it reduces recurrence (2).

Three radiation modalities are utilised in the literature: superficial X-ray, electron beam and brachytherapy. All the patients received electron beam radiotherapy within 24 hours, a timeframe supported by most published data. Lee JW and Seol KH observed a lower recurrence rate when patients began radiotherapy within 24 hours compared to 72 hours (7). Similarly, brachytherapy showed a better response when started within seven hours than when initiated within 24 hours (8). However, a recent meta-analysis reveals that the initiation of adjuvant radiotherapy after 24 hours should not significantly affect keloid recurrence (9).

The surgical method and tension-free closure should be compatible with radiotherapy. Small keloids are treated with double-layer intradermal continuous suturing, medium keloids with local flaps and large keloids (<10 cm) with microvascular flaps or skin grafts (10). Based on recurrence rates, a site-specific classification has been proposed. The anterior chest wall, scapular and suprapubic regions are considered high recurrence areas; ear keloids fall into the second category, while all other keloids are included in the third category. Therefore, a site-specific radiation dose should be planned (1). Ogawa R et al., noted that the recurrence rate reduced from 43.1% (1998-2000) to 10.6% (2012-2017) by increasing the radiation therapy dose from 15 Gy/3 Fr/3 days to 18 Gy/3 Fr/3 days (6). Bischof M et al., reported a 36% recurrence following sternal keloid excision and primary closure with adjuvant radiotherapy (11), while Lee SY and Park J, indicated that two out of three sternal keloids recurred (12).

Skin grafts are not commonly used following keloid excision and are reserved for situations when primary closure or flap options are not possible. The literature describes the use of both full-thickness and split-thickness skin grafts. The advantage is that they provide tension-free closure. However, the disadvantage is keloid formation at the donor site, which is proportional to dermal injury (13).

Pachuau L et al., administered 21 Gy in three sessions after 72 hours of surgery, reporting a 100% cure rate, which included both fully cured (94.5%) and partially cured scars. They excised the superficial and middle dermis, preserving the reticular dermis to prevent tension and aid graft take (14). Li W et al., introduced a meticulous precut technique, involving an incision made up to the subcutaneous tissue at the periphery of the keloid. Radiotherapy was administered the next day and keloid excision and grafting were performed on the following day. Adjuvant radiotherapy was given 10-14 days later. This careful approach resulted in a significantly lower recurrence rate (16.7%) compared to 55.2% in the conventional group, providing reassurance for the effectiveness of the technique (13). Long X et al., showed no recurrence in large keloids (>10 cm2) with sandwich therapy/precut therapy (15).

In the present study, the recurrence rate is 100%, which is unusually high even for sternal keloids. The authors speculate that the high recurrence rate may be attributed to the keloid’s large size, the definition of recurrence and ethnicity. Hsieh CL et al., observed a high recurrence among keloids larger than 5 cm. In the present study, most of the keloids were larger than 5 cm (9). Ogawa R et al., did not find any difference based on the size of the keloid (16). We employed the recurrence definition described by Ogawa, which includes any elevation and stiffness of the scar, with or without redness, irrespective of size and patient satisfaction was considered in the recurrence (16). The authors definition of recurrence contrasts with other studies that use terms like “cured” and “partially cured” (11),(14). The authors also believe that ethnicity may contribute to the high recurrence rate, contrary to Ogawa’s opinion (6). They feel that more randomised controlled trials from India are required to compare the conventional techniques of keloid excision, grafting and adjuvant therapy with precut/sandwich techniques to clarify keloid treatment.
 
 
Conclusion

Keloid excision combined with skin grafting, followed by adjuvant radiotherapy, is a viable option for keloid management. The adverse effects related to radiation have been found to be minimal. Since recurrences occur gradually, further studies with long-term followup are recommended to better understand the efficacy of this treatment modality.
 
REFERENCES
1.
Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and Keloids: A 2020 Update of the algorithms published 10 years ago. Plast Reconstr Surg. 2022;149(1):79-94.   [Google Scholar]  [CrossRef]  [PubMed]
2.
Mankowski P, Kanevsky J, Tomlinson J, Dyachenko A, Luc M. Optimizing radiotherapy for keloids: A meta-analysis systematic review comparing recurrence rates between different radiation modalities. Ann Plast Surg. 2017;78(4):403.   [Google Scholar]  [CrossRef]  [PubMed]
3.
Walsh LA, Wu E, Pontes D, Kwan KR, Poondru S, Miller CH, et al. Keloid treatments: An evidence-based systematic review of recent advances. Syst Rev. 2023;12:42.   [Google Scholar]  [CrossRef]  [PubMed]
4.
Mustoe TA, Cooter RD, Gold MH, Hobbs FDR, Ramelet AA, Shakespeare PG, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110(2):560-71.   [Google Scholar]  [CrossRef]  [PubMed]
5.
Liu EK, Cohen RF, Chiu ES. Radiation therapy modalities for keloid management: A critical review. J Plast Reconstr Aesthet Surg. 2022;75(8):2455-65.   [Google Scholar]  [CrossRef]  [PubMed]
6.
Ogawa R, Tosa M, Dohi T, Akaishi S, Kuribayashi S. Surgical excision and postoperative radiotherapy for keloids. Scars Burns Heal. 2019;5:2059513119891113.   [Google Scholar]  [CrossRef]  [PubMed]
7.
Lee JW, Seol KH. Adjuvant radiotherapy after surgical excision in keloids. Medicina (Mex). 2021;57(7):730.   [Google Scholar]  [CrossRef]  [PubMed]
8.
de Bakker E, van Leeuwen MCE, Meijer OWM, Niessen FB. Additional invasive techniques in scar management. In: Téot L, Mustoe TA, Middelkoop E, Gauglitz GG, editors. Textbook on scar management: state of the art management and emerging technologies [Internet]. Cham (CH): Springer; 2020 [cited 2024 Feb 5]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK586060/.   [Google Scholar]  [CrossRef]  [PubMed]
9.
Hsieh CL, Chi KY, Lin WY, Lee LTJ. Timing of adjuvant radiotherapy after keloid excision: A systematic review and meta-analysis. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2021;47(11):1438-43.   [Google Scholar]  [CrossRef]  [PubMed]
10.
The “Sandwich Therapy”: A Microsurgical Integrated Approach...: Annals of Plastic Surgery [Internet]. [cited 2024 Feb 16]. Available from: https://journals.lww. com/annalsplasticsurgery/fulltext/2017/09000/the__sandwich_therapy___a_ microsurgical_integrated.12.aspx.   [Google Scholar]
11.
Bischof M, Krempien R, Debus J, Treiber M. Postoperative electron beam radiotherapy for keloids: objective findings and patient satisfaction in self-assessment. Int J Dermatol. 2007;46(9):971-75.   [Google Scholar]  [CrossRef]  [PubMed]
12.
Lee SY, Park J. Postoperative electron beam radiotherapy for keloids: Treatment outcome and factors associated with occurrence and recurrence. Ann Dermatol. 2015;27(1):53-58.   [Google Scholar]  [CrossRef]  [PubMed]
13.
Li W, Wang Y, Wang X, Liu Z. A keloid edge precut, preradiotherapy method in large keloid skin graft treatment. Dermatol Surg. 2014;40:52-57.   [Google Scholar]  [CrossRef]  [PubMed]
14.
Pachuau L, Wu XY, Fu ML, Cui XM, Chen XD. Surgical treatment for chest “lock” keloid using autologous split-thickness skin grafting and postoperative radiotherapy. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2023;49(5S):S64-S69.   [Google Scholar]  [CrossRef]  [PubMed]
15.
Long X, Zhang M, Wang Y, Zhao R, Wang Y, Wang X. Algorithm of chest wall keloid treatment. Medicine (Baltimore). 2016;95(35):e4684.   [Google Scholar]  [CrossRef]  [PubMed]
16.
Ogawa R, Mitsuhashi K, Hyakusoku H, Miyashita T. Postoperative electron- beam irradiation therapy for keloids and hypertrophic scars: Retrospective study of 147 cases followed for more than 18 months. Plast Reconstr Surg. 2003;111(2):547-53; discussion 554-555.  [Google Scholar]  [CrossRef]
 
TABLES AND FIGURES
[Table/Fig-1] [Table/Fig-2] [Table/Fig-3] [Table/Fig-4] [Table/Fig-5]
[Table/Fig-6]
 
 
 

In This Article

  • Abstract
  • Material and Methods
  • Results
  • Discussion
  • Conclusion
  • References

Article Utilities

  • Readers Comments
  • Article in PDF
  • Citation Manager
  • How to Cite
  • Article Statistics
  • Link to PUBMED
  • Print this Article
  • Send to a Friend

Quick Links

REVIEWER
ACCESS STATISTICS
Home  |  About Us  |  Online First  |  Current Issue  |  Simple Search  |  Advance Search  |  Register  |  Login  |  Contact  |  Privacy Policy  |  Terms of Use
Author Support  |  Submit Manuscript  |  IJARS Pre-Publishing  |  Reviewer  |  Articles Archive  |  Access Statistics
©INTERNATIONAL JOURNAL OF ANATOMY RADIOLOGY & SURGERY (IJARS), ISSN : 2277-8543.
EDITORIAL OFFICE : 1/9, Roop Nagar, Delhi 11000. Phone : 01123848553

* This Journal is owned and run by medical professionals *